Bibliografía del artículo
1. Mandayam S, Jamal MM, Morgan T. Epidemiology of alcoholic liver disease. Alcohol and Alcoholic Liver Disease 24(3):217-232, 2004.
2. Rawls RA, Vega Kenneth J. Viral hepatitis in minority America. J Clin Gastroenterol 39(2):144-151, 2005.
3. Méndez Sánchez N, Villa AR, Chávez Tapia NC y col. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatology 4(1):52-55, 2005.
4. Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic diseases. J Hepatology 32(1):129-140, 2000.
5. Cannor S, Garden OJ. Bile duct injury in the era of laparoscopic cholecystectomy. Br J Surg 93:158-168, 2006.
6. Clouzeau-Girard H, Guyot Ch, Combe Ch y col. Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest 86:275-285, 2006.
7. Fernández JA, Robles R, Marín C, Sánchez-Bueno F, Ramírez P, Parrilla P. Laparoscopic iatrogeny of the hepatic hilum as an indication for liver transplantation. Liver Transpl 10(1):147-52, 2004.
8. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 31(6):1120-30, 1999.
9. Varga J. TGF-ß, smads and tissue fibrosis. Science & Medicine 6:298-307, 2002.
10. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 38(1):S38-53, 2003.
11. Ishak K, Baptista A, Bianchi L. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699, 1995.
12. Farell L. Short Course. Liver Pathology: Cirrhosis, hepatitis and primary liver tumors. Update and diagnostic Problems. Modern Pathol 13(6):679-704, 1999.
13. Roche PC, His ED. Immunohistochemestry: Theory and Practice, chapt 13. In: Morphology methods. Cell and molecular biology techniques. Ed por Ricardo V. Lloyd, MD, PhD. Humana Press, Inc. Totowa, New Jersey, pp: 229-237, 2001.
14. Moore DE, Feurer ID, Holzman MD y col. Long-term detrimental effect of bile duct injury on health-related quality of life. Arch Surg 139:476-482, 2004.
15. De Reuver PR, Dijkgraaf MGW, Gevers SKM, Gouma DJ. Poor agreement among expert witnesses in bile duct injury malpractice litigation: An expert panel survey. Ann Surg 248(5):815-820, 2008.
16. Bringener J, Richards ML, Schwesubger WH, Strodel WE, Sirinek KR. Laparoscopic cholecystectomy for elderly patients: gold standar for golden years? Arch Surg 138:531-536, 2003.
17. Melton GB, Lillemore KD, Cameron JL, Sauter PA, Coleman JA, Yeo EO CHJ. Mayor bile duct injuries associated with laparoscopic cholecystectomy: effect of surgical repair on quality of life. Ann Surg 235:888-895, 2002.
18. De Reuver PR, Grossmann I, Busch OR, Obertop H, Van Gulik TM, Gouma DJ. Referral pattern and timing of repair are risk factors for complications after reconstructive surgery for bile duct injury. Ann Surg 245(5):763-770, 2007.
19. Hermosillo Sandoval JM, Ramírez Casillas V, Hernández Hoyos S y col. Evaluación histológica de la fibrosis hepática en pacientes con lesión posquirurgica de vías biliares. Rev Med Inst Mex Seguro Soc 46(6):663-668, 2008.
20. Daniluk J, Szuster-Ciesielska A, Drabko J, Kandefer-Szersze M. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 23(1): 29-34, 2001.
21. Neuman MG, Benhamou JP. Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine 17(2):108-17, 2002.
22. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21(3):760-6, 1995.
23. Hwang S, Sung-Gyu L, Young-Joo L y col. Treatment of recurrent bile duct stricture after primary reconstruction for laparoscopic cholecystectomy-induced injury. Surg Lap Endos & Per Tech 18(5):445-449, 2008.